Investment round of Inrobics
Some projects begin with a business plan.
Inrobics It began with a question.
After years of research in social robotics and artificial intelligence, a moment arrived when we had to decide what to do with everything we had learned. We could close that chapter, publish the results, and let the work remain stored away among scientific articles, doctoral theses, and prototypes.
Or we could try to take it much further.
We choose the second option.
Not because we had all the answers, but because we had seen something we could no longer ignore: the way people reacted to a technology capable of accompanying them, motivating them, and adapting to them.
We had seen children participate in activities that had previously been more difficult for them. We had heard professionals imagine new ways to use technology. We had understood that behind every technical advance there could be a real-world application.
And that made leaving it in the laboratory no longer an option.
Turning research into a business
Starting a business with a little-known technology involves constantly explaining something that is not yet part of everyday life.
A few years ago, talking about social robots in hospitals, schools, therapy centers or nursing homes generated surprise and, in many cases, doubts.
It was understandable.
It wasn't just a matter of developing the technology. It was also necessary to demonstrate that it could be useful, safe, easy to use, and respectful of the work of professionals.
It had to be made clear that the goal was never to replace human care.
Quite the contrary.
Our vision has always been to use technology to strengthen the capabilities of those who care for, educate, rehabilitate, and support.
Over time, that idea took shape.
The prototypes became solutions. The tests led to implementations. The research continued to generate evidence. And the first people who believed in the project paved the way for others to do the same.
Behind every advance there are many people
When talking about the growth of a technology company, it's easy to think only about product, revenue, or market.
But a company like Inrobics It is also constructed in another way.
It is built with the hours that a team dedicates to solving a problem that no one will see.
With professionals who test an activity and explain how to improve it.
With centers that open their doors to new innovation.
With the users who participate, strive, and teach us how technology should evolve.
With the families who share their experiences.
And with the people who decide to support a vision before it has gone all the way.
Each one of them is part of the history of Inrobics.
That's why, when we talk about our investment round, we don't just think about funding.
We think about continuity.
Continue researching, developing, and reaching more people
The investment round of Inrobics It remains open because the company's next step requires expanding everything that has allowed us to get here.
We want to continue perfecting our social artificial intelligence platform.
We want to continue developing scientific and clinical evidence.
We want to support more professionals and deploy our solutions in new hospitals, social and healthcare centers, schools, and homes.
We want to grow in health and rehabilitation, longevity, home care, and special education.
And we want to do it without losing what defines our project: the union between science, technology and real needs.
The investment allows us to accelerate that journey.
It helps us strengthen the team, increase our development capacity, address new opportunities, and advance our commercial, scientific, and regulatory strategy.
But above all, it allows us to reduce the distance between what we know today that technology can do and all the people it has not yet reached.
A technology that is already proving its value
Inrobics It is no longer just an idea born from two doctoral theses.
Today we have more than ten years of applied research, international scientific publications and solutions deployed in real environments.
Our technology is used in hospitals, therapy centers, educational centers, residences and other specialized resources.
More than 1.000 people have interacted directly with our solutions and more than 20 centers have incorporated the technology.
The results obtained show therapeutic adherence levels above 95%, the possibility of increasing the intensity of certain interventions, and a significant reduction in the time spent by professionals on repetitive tasks.
These advances remind us why we started.
But they also show us everything that still needs to be done.
The next step is not built alone.
During years, Inrobics It has grown thanks to people who decided to look a little further.
Researchers who believed that knowledge should be turned into impact.
Professionals who saw a tool where others only saw a robot.
Institutions that opted to try a different technology.
Clients who decided to incorporate it into their centers.
A team that continues to improve every detail.
And investors who understood that behind this company there is much more than a technological trend.
There is a real need.
Health, education, and care systems need to find new ways to respond to growing demand without sacrificing quality, personalization, or humanity.
We believe that social artificial intelligence can be part of that answer.
Not as a substitute for people, but as an ally.
The investment round of Inrobics remains open
Opening this round has meant sharing an important part of our history.
Explain where we come from, what we have built, what results we are getting, and where we want to go.
It has also involved inviting new people to join the project.
The investment opportunity in Inrobics It is still available through Startupxplore.
The funding round page contains detailed information about the company, the team, the business model, the technology, the results achieved, and the objectives of this new stage.
Check out the investment opportunity in Inrobics:
https://startupxplore.com/es/inversores/invertir-startups/inrobics#info
Years ago we began this journey with more questions than certainties.
Today we have technology, evidence, clients, implementations, and a team ready to continue growing.
But we still hold the same conviction as on day one: when research manages to leave the laboratory and reach people, all the effort is worthwhile.
The round is still open.
And the story of Inrobics also.
